Publications 2024

Buschard K, Josefsen K, Krogvold L, Gerling I, Dahl-Jørgensen K, Pociot F (2024)
Influence of sphingolipid enzymes on blood glucose levels, development of diabetes, and involvement of pericytes
Diabetes Metab Res Rev, 40 (3), e3792
DOI 10.1002/dmrr.3792, PubMed 38517704

Dahl-Jørgensen K (2024)
Virus as the cause of type 1 diabetes
Trends Mol Med, 30 (11), 1020-1027
DOI 10.1016/j.molmed.2024.06.011, PubMed 39003200

Tegehall A, Ingvast S, Krogvold L, Dahl-Jørgensen K, Korsgren O (2024)
Reduced expression of central innate defense molecules in pancreatic biopsies from subjects with Type  1 diabetes
Acta Diabetol, 61 (9), 1117-1127
DOI 10.1007/s00592-024-02286-1, PubMed 38717484

Wisting L, Haugvik S, Wennersberg AL, Hage TW, Stice E, Olmsted MP, Ghaderi A, Brunborg C, Skrivarhaug T, Dahl-Jørgensen K, Rø Ø (2024)
A pilot study of a virtually delivered dissonance-based eating disorder prevention program for young women with type 1 diabetes: within-subject changes over 6-month follow-up
Eat Disord, 32 (6), 686-702
DOI 10.1080/10640266.2024.2331391, PubMed 38511886

Publications 2023

Buschard K, Jensen MH, Krogvold L, Gerling IC, Dahl-Jørgensen K, Pedersen K, Haupt-Jorgensen M (2023)
Type 1 diabetes could begin with alterations in innate anti-viral immunity, which are already at this stage associated with HLA risk haplotypes
Diabetes Metab Res Rev, 39 (7), e3678
DOI 10.1002/dmrr.3678, PubMed 37395313

Krogvold L, Mynarek IM, Ponzi E, Mørk FB, Hessel TW, Roald T, Lindblom N, Westman J, Barker P, Hyöty H, Ludvigsson J, Hanssen KF, Johannesen J, Dahl-Jørgensen K (2023)
Pleconaril and ribavirin in new-onset type 1 diabetes: a phase 2 randomized trial
Nat Med, 29 (11), 2902-2908
DOI 10.1038/s41591-023-02576-1, PubMed 37789144

Simeunovic A, Brunborg C, Heier M, Seljeflot I, Dahl-Jørgensen K, Margeirsdottir HD (2023)
Sustained low-grade inflammation in young participants with childhood onset type 1 diabetes: The Norwegian atherosclerosis and childhood diabetes (ACD) study
Atherosclerosis, 379, 117151
DOI 10.1016/j.atherosclerosis.2023.05.020, PubMed 37349194

Publications 2022

Josefsen K, Krogvold L, Gerling IC, Pociot F, Dahl-Jørgensen K, Buschard K (2022)
Development of Type 1 Diabetes may occur through a Type 2 Diabetes mechanism
Front Endocrinol (Lausanne), 13, 1032822
DOI 10.3389/fendo.2022.1032822, PubMed 36589856

Krogvold L, Genoni A, Puggioni A, Campani D, Richardson SJ, Flaxman CS, Edwin B, Buanes T, Dahl-Jørgensen K, Toniolo A (2022)
Live enteroviruses, but not other viruses, detected in human pancreas at the onset of type 1 diabetes in the DiViD study
Diabetologia, 65 (12), 2108-2120
DOI 10.1007/s00125-022-05779-2, PubMed 35953727

Krogvold L, Leete P, Mynarek IM, Russell MA, Gerling IC, Lenchik NI, Mathews C, Richardson SJ, Morgan NG, Dahl-Jørgensen K (2022)
Detection of Antiviral Tissue Responses and Increased Cell Stress in the Pancreatic Islets of Newly Diagnosed Type 1 Diabetes Patients: Results From the DiViD Study
Front Endocrinol (Lausanne), 13, 881997
DOI 10.3389/fendo.2022.881997, PubMed 35957810

Tekin H, Josefsen K, Krogvold L, Dahl-Jørgensen K, Gerling I, Pociot F, Buschard K (2022)
PDE12 in type 1 diabetes
Sci Rep, 12 (1), 18149
DOI 10.1038/s41598-022-22890-x, PubMed 36307540

Välikangas T, Lietzén N, Jaakkola MK, Krogvold L, Eike MC, Kallionpää H, Tuomela S, Mathews C, Gerling IC, Oikarinen S, Hyöty H, Dahl-Jorgensen K, Elo LL, Lahesmaa R (2022)
Pancreas Whole Tissue Transcriptomics Highlights the Role of the Exocrine Pancreas in Patients With Recently Diagnosed Type 1 Diabetes
Front Endocrinol (Lausanne), 13, 861985
DOI 10.3389/fendo.2022.861985, PubMed 35498413

Weider T, Genoni A, Broccolo F, Paulsen TH, Dahl-Jørgensen K, Toniolo A, Hammerstad SS (2022)
High Prevalence of Common Human Viruses in Thyroid Tissue
Front Endocrinol (Lausanne), 13, 938633
DOI 10.3389/fendo.2022.938633, PubMed 35909527

Publications 2021

Oikarinen S, Krogvold L, Edwin B, Buanes T, Korsgren O, Laiho JE, Oikarinen M, Ludvigsson J, Skog O, Anagandula M, Frisk G, Hyöty H, Dahl-Jørgensen K (2021)
Characterisation of enterovirus RNA detected in the pancreas and other specimens of live patients with newly diagnosed type 1 diabetes in the DiViD study
Diabetologia, 64 (11), 2491-2501
DOI 10.1007/s00125-021-05525-0, PubMed 34390364

Pedersen K, Haupt-Jorgensen M, Krogvold L, Kaur S, Gerling IC, Pociot F, Dahl-Jørgensen K, Buschard K (2021)
Genetic predisposition in the 2'-5'A pathway in the development of type 1 diabetes: potential contribution to dysregulation of innate antiviral immunity
Diabetologia, 64 (8), 1805-1815
DOI 10.1007/s00125-021-05469-5, PubMed 33973017

Poma AM, Hammerstad SS, Genoni A, Basolo A, Dahl-Jorgensen K, Toniolo A (2021)
Immune Transcriptome of Cells Infected with Enterovirus Strains Obtained from Cases of Autoimmune Thyroid Disease
Microorganisms, 9 (4)
DOI 10.3390/microorganisms9040876, PubMed 33921891

Reddy S, Krogvold L, Martin C, Sun KX, Martin O, Al-Ani A, Dahl-Jørgensen K (2021)
Expression of immunoreactive inducible nitric oxide synthase in pancreatic islet cells from newly diagnosed and long-term type 1 diabetic donors is heterogeneous and not disease-associated
Cell Tissue Res, 384 (3), 655-674
DOI 10.1007/s00441-020-03340-4, PubMed 33427953

Rodriguez-Calvo T, Krogvold L, Amirian N, Dahl-Jørgensen K, von Herrath M (2021)
One in Ten CD8⁺ Cells in the Pancreas of Living Individuals With Recent-Onset Type 1 Diabetes Recognizes the Preproinsulin Epitope PPI_15-24
Diabetes, 70 (3), 752-758
DOI 10.2337/db20-0908, PubMed 33414250

Sever D, Hershko-Moshe A, Srivastava R, Eldor R, Hibsher D, Keren-Shaul H, Amit I, Bertuzzi F, Krogvold L, Dahl-Jørgensen K, Ben-Dov IZ, Landsman L, Melloul D (2021)
NF-κB activity during pancreas development regulates adult β-cell mass by modulating neonatal β-cell proliferation and apoptosis
Cell Death Discov, 7 (1), 2
DOI 10.1038/s41420-020-00386-9, PubMed 33414444

Veiby NCBB, Simeunovic A, Heier M, Brunborg C, Saddique N, Moe MC, Dahl-Jørgensen K, Petrovski G, Margeirsdottir HD (2021)
Retinal venular oxygen saturation is associated with non-proliferative diabetic retinopathy in young patients with type 1 diabetes
Acta Ophthalmol, 100 (4), 388-394
DOI 10.1111/aos.15018, PubMed 34668632

Weider T, Richardson SJ, Morgan NG, Paulsen TH, Dahl-Jørgensen K, Hammerstad SS (2021)
HLA Class I Upregulation and Antiviral Immune Responses in Graves Disease
J Clin Endocrinol Metab, 106 (4), e1763-e1774
DOI 10.1210/clinem/dgaa958, PubMed 33367784

Wisting L, Haugvik S, Wennersberg AL, Hage TW, Stice E, Olmsted MP, Ghaderi A, Brunborg C, Skrivarhaug T, Dahl-Jørgensen K, Rø Ø (2021)
Feasibility of a virtually delivered eating disorder prevention program for young females with type 1 diabetes
Int J Eat Disord, 54 (9), 1696-1706
DOI 10.1002/eat.23578, PubMed 34245038

Publications 2020

Anderzén J, Hermann JM, Samuelsson U, Charalampopoulos D, Svensson J, Skrivarhaug T, Fröhlich-Reiterer E, Maahs DM, Akesson K, Kapellen T, Fritsch M, Birkebaek NH, Drivvoll AK, Miller K, Stephenson T, Hofer SE, Fredheim S, Kummernes SJ, Foster N, Amin R, Hilgard D, Rami-Merhar B, Dahl-Jørgensen K, Clements M, Hanas R et al. (2020)
International benchmarking in type 1 diabetes: Large difference in childhood HbA1c between eight high-income countries but similar rise during adolescence-A quality registry study
Pediatr Diabetes, 21 (4), 621-627
DOI 10.1111/pedi.13014, PubMed 32249476

Bratseth V, Margeirsdottir HD, Chiva-Blanch G, Heier M, Solheim S, Arnesen H, Dahl-Jørgensen K, Seljeflot I (2020)
Annexin V⁺ Microvesicles in Children and Adolescents with Type 1 Diabetes: A Prospective Cohort Study
J Diabetes Res, 2020, 7216863
DOI 10.1155/2020/7216863, PubMed 32309448

Bratseth V, Margeirsdottir HD, Heier M, Solheim S, Arnesen H, Dahl-Jørgensen K, Seljeflot I (2020)
Procoagulant activity in children and adolescents on intensive insulin therapy
Pediatr Diabetes, 21 (3), 496-504
DOI 10.1111/pedi.12978, PubMed 31943582

C B B Veiby N, Simeunovic A, Heier M, Brunborg C, Saddique N, Moe MC, Dahl-Jørgensen K, Margeirsdottir HD, Petrovski G (2020)
Venular oxygen saturation is increased in young patients with type 1 diabetes and mild nonproliferative diabetic retinopathy
Acta Ophthalmol, 98 (8), 800-807
DOI 10.1111/aos.14462, PubMed 32410388

Colli ML, Ramos-Rodríguez M, Nakayasu ES, Alvelos MI, Lopes M, Hill JLE, Turatsinze JV, Coomans de Brachène A, Russell MA, Raurell-Vila H, Castela A, Juan-Mateu J, Webb-Robertson BM, Krogvold L, Dahl-Jorgensen K, Marselli L, Marchetti P, Richardson SJ, Morgan NG, Metz TO, Pasquali L, Eizirik DL (2020)
An integrated multi-omics approach identifies the landscape of interferon-α-mediated responses of human pancreatic beta cells
Nat Commun, 11 (1), 2584
DOI 10.1038/s41467-020-16327-0, PubMed 32444635

Nigi L, Brusco N, Grieco GE, Licata G, Krogvold L, Marselli L, Gysemans C, Overbergh L, Marchetti P, Mathieu C, Dahl Jørgensen K, Sebastiani G, Dotta F (2020)
Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes
Front Endocrinol (Lausanne), 11, 630
DOI 10.3389/fendo.2020.00630, PubMed 33042009

Veiby NCBB, Simeunovic A, Heier M, Brunborg C, Saddique N, Moe MC, Dahl-Jørgensen K, Margeirsdottir HD, Petrovski G (2020)
Associations between Macular OCT Angiography and Nonproliferative Diabetic Retinopathy in Young Patients with Type 1 Diabetes Mellitus
J Diabetes Res, 2020, 8849116
DOI 10.1155/2020/8849116, PubMed 33313325

Weider T, Richardson SJ, Morgan NG, Paulsen TH, Dahl-Jørgensen K, Hammerstad SS (2020)
Upregulation of HLA Class I and Antiviral Tissue Responses in Hashimoto's Thyroiditis
Thyroid, 30 (3), 432-442
DOI 10.1089/thy.2019.0607, PubMed 31910110

Wisting L, Siegwarth C, Skrivarhaug T, Dahl-Jørgensen K, Rø Ø (2020)
The impact of psychological aspects, age, and BMI on eating disorder psychopathology among adult males and females with type 1 diabetes
Health Psychol Open, 7 (2), 2055102920975969
DOI 10.1177/2055102920975969, PubMed 33282331

Publications 2019

Birkebaek NH, Hermann JM, Hanberger L, Charalampopoulos D, Holl RW, Skrivarhaug T, Aakesson K, Warner JT, Drivvoll AK, Svensson AM, Stephenson T, Hofer SE, Fredheim S, Kummernes SJ, Amin R, Rami-Merhar B, Johansen A, Kapellen TM, Hilgard D, Dahl-Jørgensen K, Froehlich-Reiterer E, Fritsch M, Hanas R, Svensson J (2019)
Center Size and Glycemic Control: An International Study With 504 Centers From Seven Countries
Diabetes Care, 42 (3), e37-e39
DOI 10.2337/dc18-1253, PubMed 30659071

Dunne JL, Richardson SJ, Atkinson MA, Craig ME, Dahl-Jørgensen K, Flodström-Tullberg M, Hyöty H, Insel RA, Lernmark Å, Lloyd RE, Morgan NG, Pugliese A (2019)
Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes
Diabetologia, 62 (5), 744-753
DOI 10.1007/s00125-019-4811-7, PubMed 30675626

Dunne JL, Richardson SJ, Atkinson MA, Craig ME, Dahl-Jørgensen K, Flodström-Tullberg M, Hyöty H, Lloyd RE, Morgan NG, Pugliese A (2019)
Large enteroviral vaccination studies to prevent type 1 diabetes should be well founded and rely on scientific evidence. Reply to Skog O, Klingel K, Roivainen M et al [letter]
Diabetologia, 62 (6), 1100-1103
DOI 10.1007/s00125-019-4873-6, PubMed 31016358

Rajendran S, Anquetil F, Quesada-Masachs E, Graef M, Gonzalez N, McArdle S, Chu T, Krogvold L, Dahl-Jørgensen K, von Herrath M (2019)
IL-6 is present in beta and alpha cells in human pancreatic islets: Expression is reduced in subjects with type 1 diabetes
Clin Immunol, 211, 108320
DOI 10.1016/j.clim.2019.108320, PubMed 31809899

Russell MA, Redick SD, Blodgett DM, Richardson SJ, Leete P, Krogvold L, Dahl-Jørgensen K, Bottino R, Brissova M, Spaeth JM, Babon JAB, Haliyur R, Powers AC, Yang C, Kent SC, Derr AG, Kucukural A, Garber MG, Morgan NG, Harlan DM (2019)
HLA Class II Antigen Processing and Presentation Pathway Components Demonstrated by Transcriptome and Protein Analyses of Islet β-Cells From Donors With Type 1 Diabetes
Diabetes, 68 (5), 988-1001
DOI 10.2337/db18-0686, PubMed 30833470

Seiron P, Wiberg A, Kuric E, Krogvold L, Jahnsen FL, Dahl-Jørgensen K, Skog O, Korsgren O (2019)
Characterisation of the endocrine pancreas in type 1 diabetes: islet size is maintained but islet number is markedly reduced
J Pathol Clin Res, 5 (4), 248-255
DOI 10.1002/cjp2.140, PubMed 31493350

Wisting L, Rø A, Skrivarhaug T, Dahl-Jørgensen K, Rø Ø (2019)
Disturbed eating, illness perceptions, and coping among adults with type 1 diabetes on intensified insulin treatment, and their associations with metabolic control
J Health Psychol, 26 (5), 688-700
DOI 10.1177/1359105319840688, PubMed 30939939

Wisting L, Wonderlich J, Skrivarhaug T, Dahl-Jørgensen K, Rø Ø (2019)
Psychometric properties and factor structure of the diabetes eating problem survey - revised (DEPS-R) among adult males and females with type 1 diabetes
J Eat Disord, 7, 2
DOI 10.1186/s40337-018-0232-0, PubMed 30675355

Publications 2018

Anquetil F, Mondanelli G, Gonzalez N, Rodriguez Calvo T, Zapardiel Gonzalo J, Krogvold L, Dahl-Jørgensen K, Van den Eynde B, Orabona C, Grohmann U, von Herrath MG (2018)
Loss of IDO1 Expression From Human Pancreatic β-Cells Precedes Their Destruction During the Development of Type 1 Diabetes
Diabetes, 67 (9), 1858-1866
DOI 10.2337/db17-1281, PubMed 29945890

Charalampopoulos D, Hermann JM, Svensson J, Skrivarhaug T, Maahs DM, Akesson K, Warner JT, Holl RW, Birkebæk NH, Drivvoll AK, Miller KM, Svensson AM, Stephenson T, Hofer SE, Fredheim S, Kummernes SJ, Foster N, Hanberger L, Amin R, Rami-Merhar B, Johansen A, Dahl-Jørgensen K, Clements M, Hanas R (2018)
Exploring Variation in Glycemic Control Across and Within Eight High-Income Countries: A Cross-sectional Analysis of 64,666 Children and Adolescents With Type 1 Diabetes
Diabetes Care, 41 (6), 1180-1187
DOI 10.2337/dc17-2271, PubMed 29650804

Colli ML, Hill JLE, Marroquí L, Chaffey J, Dos Santos RS, Leete P, Coomans de Brachène A, Paula FMM, Op de Beeck A, Castela A, Marselli L, Krogvold L, Dahl-Jorgensen K, Marchetti P, Morgan NG, Richardson SJ, Eizirik DL (2018)
PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-α and-γ via IRF1 induction
EBioMedicine, 36, 367-375
DOI 10.1016/j.ebiom.2018.09.040, PubMed 30269996

Heier M, Espeland CN, Brunborg C, Seljeflot I, Margeirsdottir HD, Hanssen KF, Fugelseth D, Dahl-Jørgensen K (2018)
Preserved endothelial function in young adults with type 1 diabetes
PLoS One, 13 (10), e0206523
DOI 10.1371/journal.pone.0206523, PubMed 30359432

Heier M, Stensæth KH, Brunborg C, Seljeflot I, Margeirsdottir HD, Hanssen KF, Dahl-Jørgensen K (2018)
Increased arterial stiffness in childhood onset diabetes: a cardiovascular magnetic resonance study
Eur Heart J Cardiovasc Imaging, 19 (6), 694-700
DOI 10.1093/ehjci/jex178, PubMed 28950341

Holm LJ, Krogvold L, Hasselby JP, Kaur S, Claessens LA, Russell MA, Mathews CE, Hanssen KF, Morgan NG, Koeleman BPC, Roep BO, Gerling IC, Pociot F, Dahl-Jørgensen K, Buschard K (2018)
Abnormal islet sphingolipid metabolism in type 1 diabetes
Diabetologia, 61 (7), 1650-1661
DOI 10.1007/s00125-018-4614-2, PubMed 29671030

Horwitz E, Krogvold L, Zhitomirsky S, Swisa A, Fischman M, Lax T, Dahan T, Hurvitz N, Weinberg-Corem N, Klochendler A, Powers AC, Brissova M, Jörns A, Lenzen S, Glaser B, Dahl-Jørgensen K, Dor Y (2018)
β-Cell DNA Damage Response Promotes Islet Inflammation in Type 1 Diabetes
Diabetes, 67 (11), 2305-2318
DOI 10.2337/db17-1006, PubMed 30150306

Kuric E, Krogvold L, Hanssen KF, Dahl-Jørgensen K, Skog O, Korsgren O (2018)
No Evidence for Presence of Mucosal-Associated Invariant T Cells in the Insulitic Lesions in Patients Recently Diagnosed with Type 1 Diabetes
Am J Pathol, 188 (8), 1744-1748
DOI 10.1016/j.ajpath.2018.04.009, PubMed 29803829

Reddy S, Krogvold L, Martin C, Holland R, Choi J, Woo H, Wu F, Dahl-Jørgensen K (2018)
Distribution of IL-1β immunoreactive cells in pancreatic biopsies from living volunteers with new-onset type 1 diabetes: comparison with donors without diabetes and with longer duration of disease
Diabetologia, 61 (6), 1362-1373
DOI 10.1007/s00125-018-4600-8, PubMed 29589071

Vecchio F, Lo Buono N, Stabilini A, Nigi L, Dufort MJ, Geyer S, Rancoita PM, Cugnata F, Mandelli A, Valle A, Leete P, Mancarella F, Linsley PS, Krogvold L, Herold KC, Elding Larsson H, Richardson SJ, Morgan NG, Dahl-Jørgensen K, Sebastiani G, Dotta F, Bosi E, DRI_Biorepository Group, Type 1 Diabetes TrialNet Study Group, Battaglia M (2018)
Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes
JCI Insight, 3 (18)
DOI 10.1172/jci.insight.122146, PubMed 30232284

Wisting L, Skrivarhaug T, Dahl-Jørgensen K, Rø Ø (2018)
Prevalence of disturbed eating behavior and associated symptoms of anxiety and depression among adult males and females with type 1 diabetes
J Eat Disord, 6, 28
DOI 10.1186/s40337-018-0209-z, PubMed 30214804

Publications 2017

Brunvand L, Heier M, Brunborg C, Hanssen KF, Fugelseth D, Stensaeth KH, Dahl-Jørgensen K, Margeirsdottir HD (2017)
Advanced glycation end products in children with type 1 diabetes and early reduced diastolic heart function
BMC Cardiovasc Disord, 17 (1), 133
DOI 10.1186/s12872-017-0551-0, PubMed 28545398

Heier M, Borja MS, Brunborg C, Seljeflot I, Margeirsdottir HD, Hanssen KF, Dahl-Jørgensen K, Oda MN (2017)
Reduced HDL function in children and young adults with type 1 diabetes
Cardiovasc Diabetol, 16 (1), 85
DOI 10.1186/s12933-017-0570-2, PubMed 28683835

Kuric E, Seiron P, Krogvold L, Edwin B, Buanes T, Hanssen KF, Skog O, Dahl-Jørgensen K, Korsgren O (2017)
Demonstration of Tissue Resident Memory CD8 T Cells in Insulitic Lesions in Adult Patients with Recent-Onset Type 1 Diabetes
Am J Pathol, 187 (3), 581-588
DOI 10.1016/j.ajpath.2016.11.002, PubMed 28212742

Lundberg M, Lindqvist A, Wierup N, Krogvold L, Dahl-Jørgensen K, Skog O (2017)
The density of parasympathetic axons is reduced in the exocrine pancreas of individuals recently diagnosed with type 1 diabetes
PLoS One, 12 (6), e0179911
DOI 10.1371/journal.pone.0179911, PubMed 28628651

Martin C, Krogvold L, Farik S, Amirapu S, Wu F, Reddy S, Dahl-Jørgensen K (2017)
An immunohistochemical study of nitrotyrosine expression in pancreatic islets of cases with increasing duration of type 1 diabetes and without diabetes
Histochem Cell Biol, 147 (5), 605-623
DOI 10.1007/s00418-016-1533-5, PubMed 28154952

Rodriguez-Calvo T, Zapardiel-Gonzalo J, Amirian N, Castillo E, Lajevardi Y, Krogvold L, Dahl-Jørgensen K, von Herrath MG (2017)
Increase in Pancreatic Proinsulin and Preservation of β-Cell Mass in Autoantibody-Positive Donors Prior to Type 1 Diabetes Onset
Diabetes, 66 (5), 1334-1345
DOI 10.2337/db16-1343, PubMed 28137793

Viken MK, Flåm ST, Skrivarhaug T, Amundsen SS, Sollid LM, Drivvoll AK, Joner G, Dahl-Jørgensen K, Lie BA (2017)
HLA class II alleles in Norwegian patients with coexisting type 1 diabetes and celiac disease
HLA, 89 (5), 278-284
DOI 10.1111/tan.12986, PubMed 28247576

Westermark GT, Krogvold L, Dahl-Jørgensen K, Ludvigsson J (2017)
Islet amyloid in recent-onset type 1 diabetes-the DiViD study
Ups J Med Sci, 122 (3), 201-203
DOI 10.1080/03009734.2017.1359219, PubMed 28814132

Wisting L, Reas DL, Bang L, Skrivarhaug T, Dahl-Jørgensen K, Rø Ø (2017)
Eating patterns in adolescents with type 1 diabetes: Associations with metabolic control, insulin omission, and eating disorder pathology
Appetite, 114, 226-231
DOI 10.1016/j.appet.2017.03.035, PubMed 28351671

Publications 2016

Brunvand L, Fugelseth D, Stensaeth KH, Dahl-Jørgensen K, Margeirsdottir HD (2016)
Early reduced myocardial diastolic function in children and adolescents with type 1 diabetes mellitus a population-based study
BMC Cardiovasc Disord, 16, 103
DOI 10.1186/s12872-016-0288-1, PubMed 27225446

Hodik M, Anagandula M, Fuxe J, Krogvold L, Dahl-Jørgensen K, Hyöty H, Sarmiento L, Frisk G, POD-V Consortium (2016)
Coxsackie-adenovirus receptor expression is enhanced in pancreas from patients with type 1 diabetes
BMJ Open Diabetes Res Care, 4 (1), e000219
DOI 10.1136/bmjdrc-2016-000219, PubMed 27933184

Leete P, Willcox A, Krogvold L, Dahl-Jørgensen K, Foulis AK, Richardson SJ, Morgan NG (2016)
Differential Insulitic Profiles Determine the Extent of β-Cell Destruction and the Age at Onset of Type 1 Diabetes
Diabetes, 65 (5), 1362-9
DOI 10.2337/db15-1615, PubMed 26858360

Lundberg M, Krogvold L, Kuric E, Dahl-Jørgensen K, Skog O (2016)
Expression of Interferon-Stimulated Genes in Insulitic Pancreatic Islets of Patients Recently Diagnosed With Type 1 Diabetes
Diabetes, 65 (10), 3104-10
DOI 10.2337/db16-0616, PubMed 27422384

Richardson SJ, Rodriguez-Calvo T, Gerling IC, Mathews CE, Kaddis JS, Russell MA, Zeissler M, Leete P, Krogvold L, Dahl-Jørgensen K, von Herrath M, Pugliese A, Atkinson MA, Morgan NG (2016)
Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes
Diabetologia, 59 (11), 2448-2458
DOI 10.1007/s00125-016-4067-4, PubMed 27506584

Wisting L, Bang L, Skrivarhaug T, Dahl-Jørgensen K, Rø Ø (2016)
Psychological barriers to optimal insulin therapy: more concerns in adolescent females than males
BMJ Open Diabetes Res Care, 4 (1), e000203
DOI 10.1136/bmjdrc-2016-000203, PubMed 27403325

Publications 2015

Heier M, Margeirsdottir HD, Gaarder M, Stensæth KH, Brunborg C, Torjesen PA, Seljeflot I, Hanssen KF, Dahl-Jørgensen K (2015)
Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year follow-up study
Cardiovasc Diabetol, 14, 126
DOI 10.1186/s12933-015-0292-2, PubMed 26408307

Heier M, Margeirsdottir HD, Torjesen PA, Seljeflot I, Stensæth KH, Gaarder M, Brunborg C, Hanssen KF, Dahl-Jørgensen K (2015)
The advanced glycation end product methylglyoxal-derived hydroimidazolone-1 and early signs of atherosclerosis in childhood diabetes
Diab Vasc Dis Res, 12 (2), 139-45
DOI 10.1177/1479164114560910, PubMed 25616705

Krogvold L, Skog O, Sundström G, Edwin B, Buanes T, Hanssen KF, Ludvigsson J, Grabherr M, Korsgren O, Dahl-Jørgensen K (2015)
Function of Isolated Pancreatic Islets From Patients at Onset of Type 1 Diabetes: Insulin Secretion Can Be Restored After Some Days in a Nondiabetogenic Environment In Vitro: Results From the DiViD Study
Diabetes, 64 (7), 2506-12
DOI 10.2337/db14-1911, PubMed 25677915

Krogvold L, Wiberg A, Edwin B, Buanes T, Jahnsen FL, Hanssen KF, Larsson E, Korsgren O, Skog O, Dahl-Jørgensen K (2015)
Insulitis and characterisation of infiltrating T cells in surgical pancreatic tail resections from patients at onset of type 1 diabetes
Diabetologia, 59 (3), 492-501
DOI 10.1007/s00125-015-3820-4, PubMed 26602422

Skog O, Korsgren S, Wiberg A, Danielsson A, Edwin B, Buanes T, Krogvold L, Korsgren O, Dahl-Jørgensen K (2015)
Expression of human leukocyte antigen class I in endocrine and exocrine pancreatic tissue at onset of type 1 diabetes
Am J Pathol, 185 (1), 129-38
DOI 10.1016/j.ajpath.2014.09.004, PubMed 25524212

Wisting L, Bang L, Natvig H, Skrivarhaug T, Dahl-Jørgensen K, Lask B, Rø Ø (2015)
Metabolic Control and Illness Perceptions in Adolescents with Type 1 Diabetes
J Diabetes Res, 2016, 3486094
DOI 10.1155/2016/3486094, PubMed 26682231

Wisting L, Bang L, Skrivarhaug T, Dahl-Jørgensen K, Rø Ø (2015)
Adolescents with Type 1 Diabetes--The Impact of Gender, Age, and Health-Related Functioning on Eating Disorder Psychopathology
PLoS One, 10 (11), e0141386
DOI 10.1371/journal.pone.0141386, PubMed 26529593

Publications 2014

Hammerstad SS, Jahnsen FL, Tauriainen S, Hyöty H, Paulsen T, Norheim I, Dahl-Jørgensen K (2014)
Immunological changes and increased expression of myxovirus resistance protein a in thyroid tissue of patients with recent onset and untreated Graves' disease
Thyroid, 24 (3), 537-44
DOI 10.1089/thy.2013.0287, PubMed 24032645

Heier M, Margeirsdottir HD, Brunborg C, Hanssen KF, Dahl-Jørgensen K, Seljeflot I (2014)
Inflammation in childhood type 1 diabetes; influence of glycemic control
Atherosclerosis, 238 (1), 33-7
DOI 10.1016/j.atherosclerosis.2014.11.018, PubMed 25437887

Krogvold L, Edwin B, Buanes T, Frisk G, Skog O, Anagandula M, Korsgren O, Undlien D, Eike MC, Richardson SJ, Leete P, Morgan NG, Oikarinen S, Oikarinen M, Laiho JE, Hyöty H, Ludvigsson J, Hanssen KF, Dahl-Jørgensen K (2014)
Detection of a low-grade enteroviral infection in the islets of langerhans of living patients newly diagnosed with type 1 diabetes
Diabetes, 64 (5), 1682-7
DOI 10.2337/db14-1370, PubMed 25422108

Krogvold L, Edwin B, Buanes T, Ludvigsson J, Korsgren O, Hyöty H, Frisk G, Hanssen KF, Dahl-Jørgensen K (2014)
Pancreatic biopsy by minimal tail resection in live adult patients at the onset of type 1 diabetes: experiences from the DiViD study
Diabetologia, 57 (4), 841-3
DOI 10.1007/s00125-013-3155-y, PubMed 24429579

Sveen KA, Dahl-Jørgensen K, Stensaeth KH, Angel K, Seljeflot I, Sell DR, Monnier VM, Hanssen KF (2014)
Glucosepane and oxidative markers in skin collagen correlate with intima media thickness and arterial stiffness in long-term type 1 diabetes
J Diabetes Complications, 29 (3), 407-12
DOI 10.1016/j.jdiacomp.2014.12.011, PubMed 25600701

Sveen KA, Nerdrum T, Hanssen KF, Brekke M, Torjesen PA, Strauch CM, Sell DR, Monnier VM, Dahl-Jørgensen K, Steine K (2014)
Impaired left ventricular function and myocardial blood flow reserve in patients with long-term type 1 diabetes and no significant coronary artery disease: associations with protein glycation
Diab Vasc Dis Res, 11 (2), 84-91
DOI 10.1177/1479164113518805, PubMed 24443481

Publications 2013

Frøisland DH, Graue M, Markestad T, Skrivarhaug T, Wentzel-Larsen T, Dahl-Jørgensen K (2013)
Health-related quality of life among Norwegian children and adolescents with type 1 diabetes on intensive insulin treatment: a population-based study
Acta Paediatr, 102 (9), 889-95
DOI 10.1111/apa.12312, PubMed 23738648

Hammerstad SS, Jahnsen FL, Tauriainen S, Hyöty H, Paulsen T, Norheim I, Dahl-Jørgensen K (2013)
Inflammation and increased myxovirus resistance protein A expression in thyroid tissue in the early stages of Hashimoto's thyroiditis
Thyroid, 23 (3), 334-41
DOI 10.1089/thy.2012.0264, PubMed 22998463

Negahdar M, Aukrust I, Molnes J, Solheim MH, Johansson BB, Sagen JV, Dahl-Jørgensen K, Kulkarni RN, Søvik O, Flatmark T, Njølstad PR, Bjørkhaug L (2013)
GCK-MODY diabetes as a protein misfolding disease: the mutation R275C promotes protein misfolding, self-association and cellular degradation
Mol Cell Endocrinol, 382 (1), 55-65
DOI 10.1016/j.mce.2013.08.020, PubMed 24001579

Sveen KA, Karimé B, Jørum E, Mellgren SI, Fagerland MW, Monnier VM, Dahl-Jørgensen K, Hanssen KF (2013)
Small- and large-fiber neuropathy after 40 years of type 1 diabetes: associations with glycemic control and advanced protein glycation: the Oslo Study
Diabetes Care, 36 (11), 3712-7
DOI 10.2337/dc13-0788, PubMed 24026557

Wisting L, Frøisland DH, Skrivarhaug T, Dahl-Jørgensen K, Rø O (2013)
Psychometric properties, norms, and factor structure of the diabetes eating problem survey-revised in a large sample of children and adolescents with type 1 diabetes
Diabetes Care, 36 (8), 2198-202
DOI 10.2337/dc12-2282, PubMed 23536586

Wisting L, Frøisland DH, Skrivarhaug T, Dahl-Jørgensen K, Rø O (2013)
Disturbed eating behavior and omission of insulin in adolescents receiving intensified insulin treatment: a nationwide population-based study
Diabetes Care, 36 (11), 3382-7
DOI 10.2337/dc13-0431, PubMed 23963896

Publications 2012

Frøisland DH, Markestad T, Wentzel-Larsen T, Skrivarhaug T, Dahl-Jørgensen K, Graue M (2012)
Reliability and validity of the Norwegian child and parent versions of the DISABKIDS Chronic Generic Module (DCGM-37) and Diabetes-Specific Module (DSM-10)
Health Qual Life Outcomes, 10, 19
DOI 10.1186/1477-7525-10-19, PubMed 22300248

Hammerstad SS, Tauriainen S, Hyöty H, Paulsen T, Norheim I, Dahl-Jørgensen K (2012)
Detection of enterovirus in the thyroid tissue of patients with graves' disease
J Med Virol, 85 (3), 512-8
DOI 10.1002/jmv.23476, PubMed 23280563

Stamnes Køpp UM, Dahl-Jørgensen K, Stigum H, Frost Andersen L, Næss Ø, Nystad W (2012)
The associations between maternal pre-pregnancy body mass index or gestational weight change during pregnancy and body mass index of the child at 3 years of age
Int J Obes (Lond), 36 (10), 1325-31
DOI 10.1038/ijo.2012.140, PubMed 22929211

Publications 2011

Berg JP, Hanssen KF, Bjerve KS, Claudi T, Dahl-Jørgensen K, Rustad P, Sandberg S, Skrivarhaug T (2011)
[Standardized hemoglobin A1C for diagnostic use?]
Tidsskr Nor Laegeforen, 131 (6), 565-6
DOI 10.4045/tidsskr.10.1160, PubMed 21423304

Publications 2010

Margeirsdottir HD, Stensaeth KH, Larsen JR, Brunborg C, Dahl-Jørgensen K (2010)
Early signs of atherosclerosis in diabetic children on intensive insulin treatment: a population-based study
Diabetes Care, 33 (9), 2043-8
DOI 10.2337/dc10-0505, PubMed 20530748

Publications 2009

Bjørnvold M, Munthe-Kaas MC, Egeland T, Joner G, Dahl-Jørgensen K, Njølstad PR, Akselsen HE, Gervin K, Carlsen KC, Carlsen KH, Undlien DE (2009)
A TLR2 polymorphism is associated with type 1 diabetes and allergic asthma
Genes Immun, 10 (2), 181-7
DOI 10.1038/gene.2008.100, PubMed 19148143

Donaghue KC, Chiarelli F, Trotta D, Allgrove J, Dahl-Jorgensen K (2009)
Microvascular and macrovascular complications associated with diabetes in children and adolescents
Pediatr Diabetes, 10 Suppl 12, 195-203
DOI 10.1111/j.1399-5448.2009.00576.x, PubMed 19754630

Margeirsdottir HD, Larsen JR, Kummernes SJ, Brunborg C, Dahl-Jørgensen K (2009)
The establishment of a new national network leads to quality improvement in childhood diabetes: implementation of the ISPAD Guidelines
Pediatr Diabetes, 11 (2), 88-95
DOI 10.1111/j.1399-5448.2009.00542.x, PubMed 19552727

Publications 2008

Bjørnvold M, Undlien DE, Joner G, Dahl-Jørgensen K, Njølstad PR, Akselsen HE, Gervin K, Rønningen KS, Stene LC (2008)
Joint effects of HLA, INS, PTPN22 and CTLA4 genes on the risk of type 1 diabetes
Diabetologia, 51 (4), 589-96
DOI 10.1007/s00125-008-0932-0, PubMed 18292987

Eike MC, Olsson M, Undlien DE, Dahl-Jørgensen K, Joner G, Rønningen KS, Thorsby E, Lie BA (2008)
Genetic variants of the HLA-A, HLA-B and AIF1 loci show independent associations with type 1 diabetes in Norwegian families
Genes Immun, 10 (2), 141-50
DOI 10.1038/gene.2008.88, PubMed 18987644

Margeirsdottir HD, Larsen JR, Brunborg C, Overby NC, Dahl-Jørgensen K, Norwegian Study Group for Childhood Diabetes (2008)
High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: a population-based study
Diabetologia, 51 (4), 554-61
DOI 10.1007/s00125-007-0921-8, PubMed 18196217

Øverby NC, Margeirsdottir HD, Brunborg C, Anderssen SA, Andersen LF, Dahl-Jørgensen K, Norwegian Study Group for Childhood Diabetes (2008)
Physical activity and overweight in children and adolescents using intensified insulin treatment
Pediatr Diabetes, 10 (2), 135-41
DOI 10.1111/j.1399-5448.2008.00454.x, PubMed 18721165

Øverby NC, Margeirsdottir HD, Brunborg C, Dahl-Jørgensen K, Andersen LF, Norwegian Study Group for Childhood Diabetes (2008)
Sweets, snacking habits, and skipping meals in children and adolescents on intensive insulin treatment
Pediatr Diabetes, 9 (4 Pt 2), 393-400
DOI 10.1111/j.1399-5448.2008.00381.x, PubMed 18774998

Publications 2007

Donaghue KC, Chiarelli F, Trotta D, Allgrove J, Dahl-Jorgensen K, International Society for Pediatric and Adolescent Diabetes (2007)
ISPAD Clinical Practice Consensus Guidelines 2006-2007. Microvascular and macrovascular complications
Pediatr Diabetes, 8 (3), 163-70
DOI 10.1111/j.1399-5448.2007.00250.x, PubMed 17550427

Eike MC, Nordang GB, Karlsen TH, Boberg KM, Vatn MH, IBSEN study group, Dahl-Jørgensen K, Rønningen KS, Joner G, Flatø B, Bergquist A, Thorsby E, Førre O, Kvien TK, Undlien DE, Lie BA (2007)
The FCRL3 -169T>C polymorphism is associated with rheumatoid arthritis and shows suggestive evidence of involvement with juvenile idiopathic arthritis in a Scandinavian panel of autoimmune diseases
Ann Rheum Dis, 67 (9), 1287-91
DOI 10.1136/ard.2007.077826, PubMed 18065500

Larsen JR, Tsunoda T, Tuzcu EM, Schoenhagen P, Brekke M, Arnesen H, Hanssen KF, Nissen SE, Dahl-Jorgensen K (2007)
Intracoronary ultrasound examinations reveal significantly more advanced coronary atherosclerosis in people with type 1 diabetes than in age- and sex-matched non-diabetic controls
Diab Vasc Dis Res, 4 (1), 62-5
DOI 10.3132/dvdr.2007.009, PubMed 17469046

Margeirsdottir HD, Larsen JR, Brunborg C, Sandvik L, Dahl-Jørgensen K, Norwegian Study Group for Childhood Diabetes (2007)
Strong association between time watching television and blood glucose control in children and adolescents with type 1 diabetes
Diabetes Care, 30 (6), 1567-70
DOI 10.2337/dc06-2112, PubMed 17372157

Overby NC, Margeirsdottir HD, Brunborg C, Andersen LF, Dahl-Jørgensen K (2007)
The influence of dietary intake and meal pattern on blood glucose control in children and adolescents using intensive insulin treatment
Diabetologia, 50 (10), 2044-51
DOI 10.1007/s00125-007-0775-0, PubMed 17687538

Steine K, Larsen JR, Stugaard M, Berg TJ, Brekke M, Dahl-Jørgensen K (2007)
LV systolic impairment in patients with asymptomatic coronary heart disease and type 1 diabetes is related to coronary atherosclerosis, glycaemic control and advanced glycation endproducts
Eur J Heart Fail, 9 (10), 1044-50
DOI 10.1016/j.ejheart.2007.07.013, PubMed 17719271

Viken MK, Sollid HD, Joner G, Dahl-Jørgensen K, Rønningen KS, Undlien DE, Flatø B, Selvaag AM, Førre Ø, Kvien TK, Thorsby E, Melms A, Tolosa E, Lie BA (2007)
Polymorphisms in the cathepsin L2 (CTSL2) gene show association with type 1 diabetes and early-onset myasthenia gravis
Hum Immunol, 68 (9), 748-55
DOI 10.1016/j.humimm.2007.05.009, PubMed 17869649

Publications 2006

Bjørnvold M, Amundsen SS, Stene LC, Joner G, Dahl-Jørgensen K, Njølstad PR, Ek J, Ascher H, Gudjònsdòttir AH, Lie BA, Skinningsrud B, Akselsen HE, Rønningen KS, Sollid LM, Undlien DE (2006)
FOXP3 polymorphisms in type 1 diabetes and coeliac disease
J Autoimmun, 27 (2), 140-4
DOI 10.1016/j.jaut.2006.06.007, PubMed 16996248

Overby NC, Flaaten V, Veierød MB, Bergstad I, Margeirsdottir HD, Dahl-Jørgensen K, Andersen LF (2006)
Children and adolescents with type 1 diabetes eat a more atherosclerosis-prone diet than healthy control subjects
Diabetologia, 50 (2), 307-16
DOI 10.1007/s00125-006-0540-9, PubMed 17136391

Sagen JV, Odili S, Bjørkhaug L, Zelent D, Buettger C, Kwagh J, Stanley C, Dahl-Jørgensen K, de Beaufort C, Bell GI, Han Y, Grimsby J, Taub R, Molven A, Søvik O, Njølstad PR, Matschinsky FM (2006)
From clinicogenetic studies of maturity-onset diabetes of the young to unraveling complex mechanisms of glucokinase regulation
Diabetes, 55 (6), 1713-22
DOI 10.2337/db05-1513, PubMed 16731834

Seljeflot I, Larsen JR, Dahl-Jørgensen K, Hanssen KF, Arnesen H (2006)
Fibrinolytic activity is highly influenced by long-term glycemic control in Type 1 diabetic patients
J Thromb Haemost, 4 (3), 686-8
DOI 10.1111/j.1538-7836.2006.01803.x, PubMed 16460457

Publications 2005

Chiarelli F, Dahl-Jørgensen K, Kiess W (2005)
Diabetes in childhood and adolescence
In Pediatric and adolescent medicine, Karger, Basel, v. 10, viii, 381 s.
BIBSYS 052160580, ISBN 3-8055-7766-4

Dahl-Jørgensen K, Larsen JR, Hanssen KF (2005)
Atherosclerosis in childhood and adolescent type 1 diabetes: early disease, early treatment?
Diabetologia, 48 (8), 1445-53
DOI 10.1007/s00125-005-1832-1, PubMed 15971059

Larsen JR, Brekke M, Bergengen L, Sandvik L, Arnesen H, Hanssen KF, Dahl-Jorgensen K (2005)
Mean HbA1c over 18 years predicts carotid intima media thickness in women with type 1 diabetes
Diabetologia, 48 (4), 776-9
DOI 10.1007/s00125-005-1700-z, PubMed 15759107

Publications 2004

Larsen JR, Sjøholm H, Berg TJ, Sandvik L, Brekke M, Hanssen KF, Dahl-Jørgensen K (2004)
Eighteen years of fair glycemic control preserves cardiac autonomic function in type 1 diabetes
Diabetes Care, 27 (4), 963-6
DOI 10.2337/diacare.27.4.963, PubMed 15047656

Larsen JR, Sjøholm H, Berg TJ, Sandvik L, Brekke M, Hanssen KF, Dahl-Jørgensen K (2004)
Eighteen years of fair glycemic control preserves cardiacautonomic function in type 1 diabetes
In Diabetes care, The Association, Alexandria, VA, 27(2004)4, S. 963-6
BIBSYS 05180686x

Publications 2003

Larsen J, Bergengen L, Sandvik L, Arnesen H, Hanssen KF, Dahl-Jørgensen K (2003)
Mean HbA1c during 18 years predicts common cartoid arteryintima-media thickness in women with diabetes type 1
In Diabetes, The Association, New York, 52(2003)suppl 1, s.P687
BIBSYS 041734599

Larsen JR, Sjoholm H, Hanssen KF, Sandvik L, Berg TJ, Dahl-Jorgensen K (2003)
Optimal blood glucose control during 18 years preserves peripheral nerve function in patients with 30 years' duration of type 1 diabetes
Diabetes Care, 26 (8), 2400-4
DOI 10.2337/diacare.26.8.2400, PubMed 12882869

Larsen JR, Sjøholm H, Hanssen KF, Sandvik K, Berg TJ, Dahl-Jørgensen K (2003)
Optimal blood glucose control during 18 years preserves peripheral nerve function in patients with 30 years' duration of type 1 diabetes
In Diabetes care, The Association, Alexandria, VA, 26(2003)8, s.2400-4
BIBSYS 041719344

Publications 2002

Larsen J, Brekke M, Sandvik L, Arnesen H, Hanssen KF, Dahl-Jorgensen K (2002)
Silent coronary atheromatosis in type 1 diabetic patients and its relation to long-term glycemic control
Diabetes, 51 (8), 2637-41
DOI 10.2337/diabetes.51.8.2637, PubMed 12145181

Publications 2001

Larsen JR, Brekke M, Sandvik L, Hanssen KF, Dahl-Jørgensen K (2001)
Glycohemoglobin values over 18 years predict coronary atheromatosis in type 1 diabetics
In Diabetologia, Springer, Berlin, 44(2001)suppl 1, s.A46 Abstrakt nr 175
BIBSYS 02203546x

Publications 2000

Undlien DE, Joner G, Dahl-Jørgensen K, Rønningen KS, Nicol-Smith L, Torjesen PA, Søvik O (2000)
[Genetic and immunologic risks for development of type 1 diabetes--experiences from an intervention trial]
Tidsskr Nor Laegeforen, 120 (23), 2799-803
PubMed 11107929

Undlien DE, Joner G, Dahl-Jørgensen K, Rønningen KS, Nicol-Smith L, Torjesen PA, Søvik O (2000)
Genetisk og immunologisk risiko for type 1-diabetes: erfaringer fra en intervensjonsstudie
In Tidsskrift for Den norske legeforening, Foreningen, Oslo, 120(2000)nr. 23, S. 2799-2803
BIBSYS 010831932

Publications 1999

Dahl-Jørgensen K (1999)
Modern insulin therapy in children and adolescents
Acta Paediatr Suppl, 88 (427), 25-30
DOI 10.1111/j.1651-2227.1999.tb14336.x, PubMed 10195850

Lie BA, Todd JA, Pociot F, Nerup J, Akselsen HE, Joner G, Dahl-Jørgensen K, Rønningen KS, Thorsby E, Undlien DE (1999)
The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene
Am J Hum Genet, 64 (3), 793-800
DOI 10.1086/302283, PubMed 10053014

Publications 1998

Berg TJ, Clausen JT, Torjesen PA, Dahl-Jørgensen K, Bangstad HJ, Hanssen KF (1998)
The advanced glycation end product Nepsilon-(carboxymethyl)lysine is increased in serum from children and adolescents with type 1 diabetes
Diabetes Care, 21 (11), 1997-2002
DOI 10.2337/diacare.21.11.1997, PubMed 9802757

Dahl-Jorgensen K (1998)
Diabetic microangiopathy
Acta Paediatr., 87 425, 31-34
DOI 10.1080/080352598750030582

Dahl-Jørgensen K (1998)
Biochemical markers of diabetic microangiopathy. Past, present and future
Horm Res, 50 Suppl 1, 12-6
DOI 10.1159/000053096, PubMed 9676991

Dahl-Jørgensen K (1998)
Diabetic microangiopathy
Acta Paediatr Suppl, 425, 31-4
DOI 10.1111/j.1651-2227.1998.tb01249.x, PubMed 9822191

Publications 1997

Berg TJ, Dahl-Jørgensen K, Torjesen PA, Hanssen KF (1997)
Increased serum levels of advanced glycation end products (AGEs) in children and adolescents with IDDM
Diabetes Care, 20 (6), 1006-8
DOI 10.2337/diacare.20.6.1006, PubMed 9167115

Lie BA, Akselsen HE, Joner G, Dahl-Jørgensen K, Rønningen KS, Thorsby E, Undlien DE (1997)
HLA associations in insulin-dependent diabetes mellitus: no independent association to particular DP genes
Hum Immunol, 55 (2), 170-5
DOI 10.1016/s0198-8859(97)00095-5, PubMed 9361969

Undlien DE, Akselsen HE, Joner G, Dahl-Jørgensen K, Søvik O, Rønningen KS, Thorsby E (1997)
No independent associations of LMP2 and LMP7 polymorphisms with susceptibility to develop IDDM
Diabetes, 46 (2), 307-12
DOI 10.2337/diab.46.2.307, PubMed 9000709

Undlien DE, Friede T, Rammensee HG, Joner G, Dahl-Jørgensen K, Søvik O, Akselsen HE, Knutsen I, Rønningen KS, Thorsby E (1997)
HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection
Diabetes, 46 (1), 143-9
DOI 10.2337/diab.46.1.143, PubMed 8971095

Publications 1995

Bangstad HJ, Kierulf P, Kjaersgaard P, Mevold K, Dahl-Jørgensen K (1995)
Urinary excretion of retinol-binding protein in healthy children and adolescents
Pediatr Nephrol, 9 (3), 299-302
DOI 10.1007/BF02254190, PubMed 7632516

Undlien DE, Akselsen HE, Joner G, Dahl-Jorgensen K, Aagenaes O, Sovik O, Thorsby E, Rønningen KS (1995)
No difference in the parental origin of susceptibility HLA class II haplotypes among Norwegian patients with insulin-dependent diabetes mellitus
Am J Hum Genet, 57 (6), 1511-4
PubMed 8533785

Publications 1994

Amthor KF, Dahl-Jørgensen K, Berg TJ, Heier MS, Sandvik L, Aagenaes O, Hanssen KF (1994)
The effect of 8 years of strict glycaemic control on peripheral nerve function in IDDM patients: the Oslo Study
Diabetologia, 37 (6), 579-84
DOI 10.1007/BF00403376, PubMed 7926342

Bangstad HJ, Brinchmann-Hansen O, Hultgren S, Dahl-Jørgensen K, Hanssen KF (1994)
Impaired contrast sensitivity in adolescents and young type 1 (insulin-dependent) diabetic patients with microalbuminuria
Acta Ophthalmol (Copenh), 72 (6), 668-73
DOI 10.1111/j.1755-3768.1994.tb04677.x, PubMed 7747572

Bangstad HJ, Osterby R, Dahl-Jørgensen K, Berg KJ, Hartmann A, Hanssen KF (1994)
Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy
Diabetologia, 37 (5), 483-90
DOI 10.1007/s001250050136, PubMed 8056186

Dahl-Jørgensen K, Brinchmann-Hansen O, Bangstad HJ, Hanssen KF (1994)
Blood glucose control and microvascular complications--what do we do now?
Diabetologia, 37 (12), 1172-7
DOI 10.1007/BF00399789, PubMed 7895945

Normann EK, Evald U, Dahl-Jørgensen K, Larsen S, Norman N, Tuvemo T (1994)
Decreased serum insulin-like growth factor I during puberty in children with insulin dependent diabetes mellitus (IDDM)
Ups J Med Sci, 99 (2), 147-54
DOI 10.3109/03009739409179358, PubMed 7716826

Publications 1993

Bangstad HJ, Dahl-Jørgensen K, Kjaersgaard P, Mevold K, Hanssen KF (1993)
Urinary albumin excretion rate and puberty in non-diabetic children and adolescents
Acta Paediatr, 82 (10), 857-62
DOI 10.1111/j.1651-2227.1993.tb17628.x, PubMed 8241647

Bangstad HJ, Osterby R, Dahl-Jørgensen K, Berg KJ, Hartmann A, Nyberg G, Frahm Bjørn S, Hanssen KF (1993)
Early glomerulopathy is present in young, type 1 (insulin-dependent) diabetic patients with microalbuminuria
Diabetologia, 36 (6), 523-9
DOI 10.1007/BF02743268, PubMed 8335174

Brinchmann-Hansen O, Bangstad HJ, Hultgren S, Fletcher R, Dahl-Jørgensen K, Hanssen KF, Sandvik L (1993)
Psychophysical visual function, retinopathy, and glycemic control in insulin-dependent diabetics with normal visual acuity
Acta Ophthalmol (Copenh), 71 (2), 230-7
DOI 10.1111/j.1755-3768.1993.tb04996.x, PubMed 8333271

Hanssen KF, Dahl-Jørgensen K, Brinchmann-Hansen O (1993)
[Blood glucose level means everything]
Tidsskr Nor Laegeforen, 113 (23), 2890-1
PubMed 8236187

Publications 1992

Bangstad HJ, Kofoed-Enevoldsen A, Dahl-Jørgensen K, Hanssen KF (1992)
Glomerular charge selectivity and the influence of improved blood glucose control in type 1 (insulin-dependent) diabetic patients with microalbuminuria
Diabetologia, 35 (12), 1165-9
DOI 10.1007/BF00401371, PubMed 1478369

Brinchmann-Hansen O, Dahl-Jørgensen K, Hanssen KF, Sandvik L (1992)
Oscillatory potentials, retinopathy, and long-term glucose control in insulin-dependent diabetes
Acta Ophthalmol (Copenh), 70 (6), 705-12
DOI 10.1111/j.1755-3768.1992.tb04873.x, PubMed 1488874

Brinchmann-Hansen O, Dahl-Jørgensen K, Hanssen KF, Sandvik L (1992)
Macular recovery time, diabetic retinopathy, and clinical variables after 7 years of improved glycemic control
Acta Ophthalmol (Copenh), 70 (2), 235-42
DOI 10.1111/j.1755-3768.1992.tb04130.x, PubMed 1609574

Brinchmann-Hansen O, Dahl-Jørgensen K, Sandvik L, Hanssen KF (1992)
Blood glucose concentrations and progression of diabetic retinopathy: the seven year results of the Oslo study
BMJ, 304 (6818), 19-22
DOI 10.1136/bmj.304.6818.19, PubMed 1734985

Dahl-Jørgensen K, Bjøro T, Kierulf P, Sandvik L, Bangstad HJ, Hanssen KF (1992)
Long-term glycemic control and kidney function in insulin-dependent diabetes mellitus
Kidney Int, 41 (4), 920-3
DOI 10.1038/ki.1992.140, PubMed 1513113

Dahl-Jørgensen K, Glosli H, Joner G, Rønningen KS, Søvik O (1992)
[Can type 1 diabetes be prevented?]
Tidsskr Nor Laegeforen, 112 (23), 2951-2
PubMed 1412340

Hanssen KF, Bangstad HJ, Brinchmann-Hansen O, Dahl-Jørgensen K (1992)
Blood glucose control and diabetic microvascular complications: long-term effects of near-normoglycaemia
Diabet Med, 9 (8), 697-705
DOI 10.1111/j.1464-5491.1992.tb01876.x, PubMed 1395460

Publications 1991

Bangstad HJ, Try K, Dahl-Jørgensen K, Hanssen KF (1991)
New semiquantitative dipstick test for microalbuminuria
Diabetes Care, 14 (11), 1094-7
DOI 10.2337/diacare.14.11.1094, PubMed 1797496

Dahl-Jørgensen K, Joner G, Hanssen KF (1991)
Relationship between cows' milk consumption and incidence of IDDM in childhood
Diabetes Care, 14 (11), 1081-3
DOI 10.2337/diacare.14.11.1081, PubMed 1797491

Kapelrud H, Bangstad HJ, Dahl-Jørgensen K, Berg K, Hanssen KF (1991)
Serum Lp(a) lipoprotein concentrations in insulin dependent diabetic patients with microalbuminuria
BMJ, 303 (6804), 675-8
DOI 10.1136/bmj.303.6804.675, PubMed 1833011

Normann EK, Trygstad O, Larsen S, Dahl-Jørgensen K (1991)
Height reduction in 539 tall girls treated with three different dosages of ethinyloestradiol
Arch Dis Child, 66 (11), 1275-8
DOI 10.1136/adc.66.11.1275, PubMed 1755636

Publications 1990

Hanssen KF, Bangstad HJ, Brinchman-Hansen O, Dahl-Jørgensen K (1990)
Glycemic control, incipient diabetic nephropathy, and diabetic retinopathy
J Diabet Complications, 4 (2), 66-7
DOI 10.1016/0891-6632(90)90035-4, PubMed 2145303

Haakens K, Hanssen KF, Dahl-Jørgensen K, Vaaler S, Aagenaes O, Mosand R (1990)
Continuous subcutaneous insulin infusion (CSII), multiple injections (MI) and conventional insulin therapy (CT) in self-selecting insulin-dependent diabetic patients. A comparison of metabolic control, acute complications and patient preferences
J Intern Med, 228 (5), 457-64
DOI 10.1111/j.1365-2796.1990.tb00263.x, PubMed 2254715

Publications 1989

Bangstad HJ, Hanssen KF, Dahl-Jørgensen K, Aagenaes O (1989)
Microalbuminuria is associated with long term poor glycemic control in adolescent insulin dependent diabetics
Diabetes Res, 12 (2), 71-4
PubMed 2634509

Haakens K, Hanssen KF, Dahl-Jørgensen K, Vaaler S, Torjesen P, Try K (1989)
Early morning glycaemia and the metabolic consequences of delaying breakfast/morning insulin. A comparison of continuous subcutaneous insulin infusion and multiple injection therapy with human isophane or human ultralente insulin at bedtime in insulin-dependent diabetics
Scand J Clin Lab Invest, 49 (7), 653-9
DOI 10.3109/00365518909091541, PubMed 2692136

Publications 1988

Bangstad HJ, Dahl-Jørgensen K, Aagenaes O, Hanssen KF, Kierulf P (1988)
[Microalbuminuria. An important marker for diabetic nephropathy and macrovascular disease]
Tidsskr Nor Laegeforen, 108 (26), 2168-70
PubMed 3206421

Brinchmann-Hansen O, Dahl-Jørgensen K, Hanssen KF, Sandvik L (1988)
The response of diabetic retinopathy to 41 months of multiple insulin injections, insulin pumps, and conventional insulin therapy
Arch Ophthalmol, 106 (9), 1242-6
DOI 10.1001/archopht.1988.01060140402041, PubMed 3046587

Brinchmann-Hansen O, Dahl-Jørgensen K, Hanssen KF, Sandvik L (1988)
Effects of intensified insulin treatment on retinal vessels in diabetic patients
Br J Ophthalmol, 72 (9), 666-73
DOI 10.1136/bjo.72.9.666, PubMed 3052571

Brinchmann-Hansen O, Dahl-Jørgensen K, Hanssen KF, Sandvik L (1988)
Oscillatory potentials, macular recovery time, and diabetic retinopathy through 3 years of intensified insulin treatment
Ophthalmology, 95 (10), 1358-66
DOI 10.1016/s0161-6420(88)33010-1, PubMed 3067179

Dahl-Jørgensen K, Hanssen KF (1988)
[Can good blood sugar regulation prevent diabetic complications?]
Nord Med, 103 (12), 343-4
PubMed 3200703

Dahl-Jørgensen K, Hanssen KF, Kierulf P, Bjøro T, Sandvik L, Aagenaes O (1988)
Reduction of urinary albumin excretion after 4 years of continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus. The Oslo Study
Acta Endocrinol (Copenh), 117 (1), 19-25
DOI 10.1530/acta.0.1170019, PubMed 3289293

Hanssen KF, Brinchmann-Hansen O, Dahl-Jørgensen K, Sandvik L (1988)
[Effect of intensive treatment on diabetic retinopathy]
Journ Annu Diabetol Hotel Dieu, 167-73
PubMed 3050220

Rosenlund EF, Haakens K, Brinchmann-Hansen O, Dahl-Jørgensen K, Hanssen KF (1988)
Transient proliferative diabetic retinopathy during intensified insulin treatment
Am J Ophthalmol, 105 (6), 618-25
DOI 10.1016/0002-9394(88)90054-2, PubMed 3287938

Publications 1987

Bangstad HJ, Hanssen KF, Kierulf P, Larsen S, Dahl-Jørgensen K, Joø GB, Aagenaes O (1987)
Elevated albumin excretion rate is common among poorly controlled adolescent insulin dependent diabetics
Diabetes Res, 6 (1), 43-6
PubMed 3690956

Brinchmann-Hansen O, Myhre K, Dahl-Jørgensen K, Hanssen KF, Sandvik L (1987)
The central light reflex of retinal arteries and veins in insulin-dependent diabetic subjects
Acta Ophthalmol (Copenh), 65 (4), 474-80
DOI 10.1111/j.1755-3768.1987.tb07026.x, PubMed 3661146

Dahl-Jørgensen K (1987)
Near-normoglycemia and late diabetic complications. The Oslo Study
Acta Endocrinol Suppl (Copenh), 284, 1-38
PubMed 3300128

Dahl-Jørgensen K, Torjesen P, Hanssen KF, Sandvik L, Aagenaes O (1987)
Increase in insulin antibodies during continuous subcutaneous insulin infusion and multiple-injection therapy in contrast to conventional treatment
Diabetes, 36 (1), 1-5
DOI 10.2337/diab.36.1.1, PubMed 3539672

Publications 1986

Dahl-Jørgensen K (1986)
Near-normoglycemia and late diabetic complications: the Oslo study
In Acta endocrinologica, Supplementum, Periodica, Copenhagen, 284, 38 s.
BIBSYS 87216618x, ISBN 87-7494-318-9

Dahl-Jørgensen K (1986)
Near-normoglycemia and late diabetic complications: the Oslo study : (original articles)
Aker hospital, University of Norway, Oslo, 1 b.(flere pag.)
BIBSYS 874111668

Dahl-Jørgensen K, Brinchmann-Hansen O, Hanssen KF, Ganes T, Kierulf P, Smeland E, Sandvik L, Aagenaes O (1986)
Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study
Br Med J (Clin Res Ed), 293 (6556), 1195-9
DOI 10.1136/bmj.293.6556.1195, PubMed 3096429

Hanssen KF, Dahl-Jørgensen K, Lauritzen T, Feldt-Rasmussen B, Brinchmann-Hansen O, Deckert T (1986)
Diabetic control and microvascular complications: the near-normoglycaemic experience
Diabetologia, 29 (10), 677-84
DOI 10.1007/BF00870275, PubMed 3542669

Skare S, Dahl-Jørgensen K, Kriz V, Hanssen KF (1986)
Plasma somatostatin and plasma glucagon in long-term IDDM without residual B-cell function. No effect of different long-term metabolic control
Scand J Clin Lab Invest, 46 (7), 635-8
DOI 10.3109/00365518609083725, PubMed 2878490

Vaaler S, Hanssen KF, Dahl-Jørgensen K, Frølich W, Aaseth J, Odegaard B, Aagenaes O (1986)
Diabetic control is improved by guar gum and wheat bran supplementation
Diabet Med, 3 (3), 230-3
DOI 10.1111/j.1464-5491.1986.tb00750.x, PubMed 3030619

Publications 1985

Brinchmann-Hansen O, Dahl-Jørgensen K, Hanssen KF, Sandvik L (1985)
Effects of intensified insulin treatment on various lesions of diabetic retinopathy
Am J Ophthalmol, 100 (5), 644-53
DOI 10.1016/0002-9394(85)90618-x, PubMed 3904464

Dahl-Jørgensen K, Brinchmann-Hansen O, Hanssen KF, Sandvik L, Aagenaes O (1985)
Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study
Br Med J (Clin Res Ed), 290 (6471), 811-5
DOI 10.1136/bmj.290.6471.811, PubMed 3919804

Hanssen KF, Dahl-Jørgensen K, Brinchmann-Hansen O (1985)
The influence of strict control on diabetic complications
Acta Endocrinol Suppl (Copenh), 272, 57-60
DOI 10.1530/acta.0.110s057, PubMed 3914805

Skare S, Dahl-Jørgensen K, Hanssen KF, Norman N (1985)
Increased peripheral venous somatostatin concentration and decreased glucagon response to arginine in patients with insulin dependent diabetes mellitus without residual B-cell function. Increased plasma SRIF in IDDM
Acta Endocrinol (Copenh), 109 (4), 517-21
DOI 10.1530/acta.0.1090517, PubMed 2863913

Publications 1984

Dahl-Jørgensen K, Hanssen KF, Aagenaes O, Haider T (1984)
[Determination of urinary glucose. Simple determination of urinary glucose with a new semi-quantitative reagent stick; the Diabur Test 5000]
Tidsskr Nor Laegeforen, 104 (26), 1803-6
PubMed 6495272

Dahl-Jørgensen K, Hanssen KF, Aagenaes O, Larsen S (1984)
[New methods for subcutaneous insulin administration. A year's experience with the insulin pump and multiple insulin injection therapy]
Tidsskr Nor Laegeforen, 104 (13), 856-61
PubMed 6379982

Publications 1983

Knudtzon J, Dahl-Jørgensen K, Meen HD, Baevre H, Søvik O (1983)
[Children and adolescents with diabetes mellitus. Understanding correlation between glycosylated hemoglobin and diabetes mellitus and its management]
Tidsskr Nor Laegeforen, 103 (5), 516-8
PubMed 6346580

Publications 1982

Dahl-Jørgensen K, Larsen AE (1982)
HbA1 determination by agar gel electrophoresis after elimination of labile HbA1: a comparison with ion-exchange chromatography
Scand J Clin Lab Invest, 42 (1), 27-33
DOI 10.1080/00365518209168046, PubMed 7134788

Maehlum S, Dahl-Jørgensen K, Meen HD (1982)
Diabetes mellitus and physical activity
Scand J Soc Med Suppl, 29, 209-16
PubMed 6753136

Publications 1981

Hanssen KF, Dahl-Jørgensen K, Abyholm AS (1981)
[Diabetic control. Self control of urinary and blood glucose and measurement of glycosylated hemoglobin (HbA1)]
Tidsskr Nor Laegeforen, 101 (13), 780-4
PubMed 7268712

Publications 1980

Dahl-Jørgensen K, Meen HD, Hanssen KF, Aagenaes O (1980)
The effect of exercise on diabetic control and hemoglobin A1 (HbA1) in children
Acta Paediatr Scand Suppl, 283, 53-6
DOI 10.1111/j.1651-2227.1980.tb15313.x, PubMed 6938115

Maehlum S, Dahl-Jørgensen K, Meen HD (1980)
[Diabetes and physical activity]
Tidsskr Nor Laegeforen, 100 (12B), 840-4
PubMed 6996213

Publications 1979

Dahl-Jørgensen K, Michalsen H (1979)
Adynamia episodica hereditaria. Treatment with salbutamol
Acta Paediatr Scand, 68 (4), 583-5
DOI 10.1111/j.1651-2227.1979.tb05059.x, PubMed 463542